Can the (√n+1) Rule be accepted in Sampling Plans?
Recommendation
Tuesday, 4 February 2025 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
Is a sampling plan based on the (√n+1) rule acceptable for determining the correct number of samples? The Canadian health authority (Health Canada) listed this question in the section "Good Manufacturing Practices (GMP) Questions and Answers" of their website and answered it as follows:
Sampling plans and procedures must be statistically valid and based on scientifically sound sampling practices.
Among the important issues to be considered regarding the risks are:
- the previously determined classification of defects,
- the criticality of the material,
- the previous quality history of the supplier.
A sampling plan based on (√n+1) may generally be acceptable, e.g. for a large number of containers. However, such a sampling plan may pose a considerable risk of accepting defect goods when sampling a small number of containers, for example.
A documented justification is expected for all sampling plans.
Strictly speaking, these requirements only apply for der Canadian market, they can, however, be viewed as state of the art worldwide.
The question with its complete answer can be found in section "Raw Material Testing - C.02.009 & C.02.010" under Q7 - see
"Good Manufacturing Practices (GMP) Questions and Answers / Is the sampling plan based on the (√n+1) acceptable for identifying the number of containers of raw material to be sampled?"
Related GMP News
11.12.2024Another FDA Warning Letter Based on Review of Records
04.12.2024FDA Warning Letter to South African OTC Drug Manufacturer
02.12.2024How to keep Analytical Systems Current and Compliant
27.11.2024FDA Inspections in the EU: Warning Letter to Italian OTC Drug Manufacturer
21.11.2024New GMP Journal Article on Analytical Instrument Qualification and System Validation
21.11.2024FDA Warns Chinese OTC Drug Manufacturer Following Review of Records